Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
CT-7439 by Carrick Therapeutics for Breast Cancer: Likelihood of Approval
CT-7439 is under clinical development by Carrick Therapeutics and currently in Phase I for Breast Cancer. According to GlobalData, Phase...
Samuraciclib by Carrick Therapeutics for Small-Cell Lung Cancer: Likelihood of Approval
Samuraciclib is under clinical development by Carrick Therapeutics and currently in Phase II for Small-Cell Lung Cancer. According to GlobalData,...
Samuraciclib by Carrick Therapeutics for Ovarian Cancer: Likelihood of Approval
Samuraciclib is under clinical development by Carrick Therapeutics and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase...
CT-7439 by Carrick Therapeutics for Solid Tumor: Likelihood of Approval
CT-7439 is under clinical development by Carrick Therapeutics and currently in Phase II for Solid Tumor. According to GlobalData, Phase...